Literature DB >> 8709263

Localization of human T-cell leukemia virus type 1 tax to subnuclear compartments that overlap with interchromatin speckles.

O J Semmes1, K T Jeang.   

Abstract

Tax, the virally encoded activator of the human T-cell leukemia virus type 1 long terminal repeats, regulates the expression of many cellular genes. This protein has been implicated in transformation events leading to the development of adult T-cell leukemia. Because subcellular localization contributes importantly to protein function, we determined the compartment(s) within the cell in which Tax is found. Using confocal microscopy, we found that Tax localizes to subnuclear domains which overlap with structures previously identified as interchromatin granules or spliceosomal speckles. These Tax speckled structures are coincident with a subset of nuclear transcriptional hot spots. Disruption of the Tax speckled structures by heat shock revealed the existence of different populations of Tax. One population of Tax is tightly associated with nuclear speckles. A second population exists outside of the speckles and is transcriptionally active for some promoters.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709263      PMCID: PMC190661          DOI: 10.1128/JVI.70.9.6347-6357.1996

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

Review 1.  Mechanisms of human T-cell leukemia virus-induced leukemogenesis.

Authors:  G Feuer; I S Chen
Journal:  Biochim Biophys Acta       Date:  1992-12-16

Review 2.  The human T-cell leukemia virus (HTLV) transactivator (Tax) protein.

Authors:  J Sodroski
Journal:  Biochim Biophys Acta       Date:  1992-09-14

3.  Detection and characterization of a factor which rescues spliceosome assembly from a heat-inactivated HeLa cell nuclear extract.

Authors:  P Delannoy; M H Caruthers
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

4.  Multiple tandemly repeated binding sites for cellular nuclear factor 1 that surround the major immediate-early promoters of simian and human cytomegalovirus.

Authors:  K T Jeang; D R Rawlins; P J Rosenfeld; J H Shero; T J Kelly; G S Hayward
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

5.  Normal and mutant human beta-globin pre-mRNAs are faithfully and efficiently spliced in vitro.

Authors:  A R Krainer; T Maniatis; B Ruskin; M R Green
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

6.  Mutational analysis of human T-cell leukemia virus type I Tax: regions necessary for function determined with 47 mutant proteins.

Authors:  O J Semmes; K T Jeang
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

7.  The amino terminus of Tax is required for interaction with the cyclic AMP response element binding protein.

Authors:  I Goren; O J Semmes; K T Jeang; K Moelling
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

8.  Protein domains involved in both in vivo and in vitro interactions between human T-cell leukemia virus type I tax and CREB.

Authors:  M J Yin; E J Paulssen; J S Seeler; R B Gaynor
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

9.  Direct evidence that p40x of human T-cell leukemia virus type I is a trans-acting transcriptional activator.

Authors:  M Seiki; J Inoue; T Takeda; M Yoshida
Journal:  EMBO J       Date:  1986-03       Impact factor: 11.598

10.  Binding of the HTLV-I Tax1 transactivator to the inducible 21 bp enhancer is mediated by the cellular factor HEB1.

Authors:  C Béraud; G Lombard-Platet; Y Michal; P Jalinot
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  55 in total

1.  Human T-cell lymphotropic virus type 3: complete nucleotide sequence and characterization of the human tax3 protein.

Authors:  Sara Calattini; Sébastien Alain Chevalier; Renan Duprez; Philippe Afonso; Alain Froment; Antoine Gessain; Renaud Mahieux
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Mutational analysis of human T-cell leukemia virus type 2 Tax.

Authors:  T M Ross; A C Minella; Z Y Fang; S M Pettiford; P L Green
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Characterization of mammalian Par 6 as a dual-location protein.

Authors:  Erin G Cline; W James Nelson
Journal:  Mol Cell Biol       Date:  2007-04-09       Impact factor: 4.272

4.  Dimerization and a novel Tax speckled structure localization signal are required for Tax nuclear localization.

Authors:  Kimberly A Fryrear; Sarah S Durkin; Saurabh K Gupta; Jessica B Tiedebohl; O John Semmes
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

5.  Phosphorylation of the human T-cell leukemia virus type 1 transactivator tax on adjacent serine residues is critical for tax activation.

Authors:  F Bex; K Murphy; R Wattiez; A Burny; R B Gaynor
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

6.  Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles.

Authors:  Vibeke Andresen; Cynthia A Pise-Masison; Uma Sinha-Datta; Marcia Bellon; Valerio Valeri; Robyn Washington Parks; Valentina Cecchinato; Risaku Fukumoto; Christophe Nicot; Genoveffa Franchini
Journal:  Blood       Date:  2011-06-15       Impact factor: 22.113

7.  HTLV-I Tax self-association in optimal trans-activation function.

Authors:  D Y Jin; K T Jeang
Journal:  Nucleic Acids Res       Date:  1997-01-15       Impact factor: 16.971

8.  Retroviral cyclin enhances cyclin-dependent kinase-8 activity.

Authors:  Joel Rovnak; Connie D Brewster; Sandra L Quackenbush
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

Review 9.  Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses.

Authors:  Zhi-Ming Zheng
Journal:  Int J Biol Sci       Date:  2010-12-01       Impact factor: 6.580

10.  The viral oncoprotein tax sequesters DNA damage response factors by tethering MDC1 to chromatin.

Authors:  S Mehdi Belgnaoui; Kimberly A Fryrear; Julius O Nyalwidhe; Xin Guo; O John Semmes
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.